The Vasopressin (ADH) System: Water Balance, Blood Pressure, and Its Therapeutic Analogs

Few hormones illustrate the logic of peptide drug design better than vasopressin. A single nine-amino-acid molecule controls both how much water your body keeps and how tightly your blood vessels squeeze — and by re-engineering which of those two jobs a molecule does, chemists produced three medicines used for utterly different problems: desmopressin, terlipressin, and vasopressin itself.

What vasopressin is

Vasopressin — also called arginine vasopressin (AVP) or antidiuretic hormone (ADH) — is made by neurons in the hypothalamus and released from the posterior pituitary into the bloodstream. Its release is triggered mainly by two signals: rising blood concentration (osmolality), detected by osmoreceptors in the brain, and falling blood volume or pressure, detected by baroreceptors. In other words, the body releases vasopressin when it is either too concentrated or running low on circulating volume.

Two receptors, two jobs

Vasopressin's effects split across different receptor subtypes, and this split is the key to everything downstream:

• V2 receptors, in the kidney's collecting ducts, drive the antidiuretic effect. When activated, they insert aquaporin-2 water channels into the tubule wall, letting the kidney reabsorb water and produce concentrated urine. This is how the body conserves water.
• V1a receptors, on the smooth muscle of blood vessels, drive vasoconstriction — tightening vessels and raising blood pressure.
• V1b receptors, in the pituitary, contribute to the stress response by promoting ACTH release.

A hormone that both conserves water and constricts vessels is exactly what you want in acute blood loss or dehydration — but as a drug, you usually want only one of those actions at a time.

Splitting the molecule's jobs into medicines

This is where the analogs come in:

• Desmopressin (DDAVP) was engineered to be V2-selective and resistant to breakdown. It gives the water-conserving effect without meaningful vasoconstriction — ideal for central diabetes insipidus, bedwetting, and nocturia. As a bonus, V2 stimulation releases clotting factors (von Willebrand factor and factor VIII), so desmopressin also treats mild bleeding disorders.
• Terlipressin keeps meaningful V1 activity and is a slow-release prodrug. Its vasoconstriction is used deliberately to tighten the over-dilated gut circulation in hepatorenal syndrome and to lower portal pressure in variceal bleeding.
• Vasopressin itself, short-acting and non-selective, is used as an ICU vasopressor in septic shock, where its V1 vasoconstriction raises blood pressure through a pathway independent of standard catecholamine drugs.

When the system goes wrong

Two mirror-image disorders show what happens when vasopressin signaling is off:

• Diabetes insipidus — too little vasopressin (central) or a kidney that can't respond to it (nephrogenic) — causes large volumes of dilute urine and intense thirst. The central form is treated with desmopressin.
• SIADH (syndrome of inappropriate antidiuretic hormone) — too much ADH activity — causes the body to retain water and dilute its sodium, leading to hyponatremia. Treatment focuses on the cause and on fluid or sodium management, sometimes with vasopressin-receptor blockers ("vaptans").

The recurring safety theme: sodium

Because the V2 effect is all about holding water, the shadow side of every antidiuretic use is hyponatremia — dangerously low blood sodium from retaining too much water. This is why desmopressin dosing comes with fluid restriction and sodium monitoring, and why the vasoconstrictor analogs are used only under close hospital supervision.

Key takeaways

• Vasopressin (ADH) is a nine-amino-acid hormone that conserves water (via V2 receptors) and constricts blood vessels (via V1 receptors).
• Selectively engineering these actions produced three distinct medicines: V2-selective desmopressin, V1-active terlipressin, and native vasopressin as a vasopressor.
• Disorders of the system — diabetes insipidus and SIADH — are mirror images of too little versus too much ADH activity.
• The defining safety concern for antidiuretic use is hyponatremia from water retention.

This article is educational and does not constitute medical advice. Vasopressin and its analogs are prescription medicines used under clinical supervision.